[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@pick1998_2 Avatar @pick1998_2 Nick zheng

Nick zheng posts on X about discount, $clrb, c3, $apls the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social topic influence discount, $clrb, c3, $apls

Top accounts mentioned or mentioned by @fireworkstrades @nolastevedore @jfais20 @jdbell20 @mattnachtrab @lcccc333 @ascendingbio @biotechnerd1 @af2communicate @bymadeleinea @evaluatevantage @jq1234t @juhwa18 @jul05310473john @bioclouseau @maxoluibikunle @adamfeuerstein @achillestxcom @melvinriskmgmt @lramseu

Top assets mentioned Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Top Social Posts #


Top posts by engagements in the last XX hours

"$CLRB insiders are buying after r-split and financing at discount. Will FDA BTD bring this biotech stock back to life"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-03 16:55:43 UTC 6931 followers, 1462 engagements

"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-18 15:32:36 UTC 6927 followers, 1251 engagements